Saks, Nordstrom, Ma...
Health Care: Health Services
Enzo Biochem Inc. (ENZ: NYSE)
$2.27 0.02 | 0.88%
05/21/13 - 02:35 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.25 |
| 52 Week High | 3.16 |
| 52 Week Low | 1.33 |
| Avg. Daily Vol. (Mil) | 0.10 |
| Beta (3 year) | 1.94 |
| Share Related Items | |
| Mkt Cap (Mil) | 88.60 |
| Shares Out (Mil) | 39.38 |
| Float (Mil) | 31.64 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.10 |
| Current Ratio | 1.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.88 |
| Price/Book | 2.20 |
| Price/Cash Flow | -79.10 |
| Per Share Data | |
| Earnings | -1.02 |
| Sales | 2.54 |
| Book Value | 1.02 |
| Cash Flow | -0.03 |
| Business Summary | |
|---|---|
| Enzo Biochem, Inc. is engaged in research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. | |
| General Information | |
| 527 Madison Avenue
New York, NY 10022 |
|
| www.enzo.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 467 | |
| CEO: Dr. Elazar Rabbani,PhD | |
| Short Interest | |
| Current Month (Mil) | 0.46 |
| Previous Month (Mil) | 0.44 |
| Short Interest Ratio (Days) | 2.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -9.10 |
| Return on Investments | -14.00 |
| Profitability | |
| Gross Margin | 48.60 |
| EBIT Margin | -42.00 |
| Profit Margin | -5.70 |
Portfolios with ENZ
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserBarron's Insider Purchases ...
- ContributorStockerblog.com Gene Therap...
- Userkelvinenz Portfolio 1
- UserS-0022
- UserTraderSteveUK Portfolio 1
- UserRT_in_CA
- UserSo far, I'm beating the S&a...
Latest ENZ Headlines from TheStreet
- Interesting ENZ Call For January 2014 05.20.13 | 12:05 pm
- 4 Big Volume Gainers Under $10 11.13.12 | 06:11 pm
- 5 Stocks Poised for Breakouts 09.21.12 | 12:09 pm
- Thursday Earnings Live Blog 10.14.10 | 04:10 pm
- Investors May See Upside Down Under 09.16.10 | 08:09 am
- Enzo Biochem 1Q Loss Narrows On Revenue Boost 12.10.09 | 04:12 pm
- Enzo Biochem 4Q Loss Widens On Costs 10.14.09 | 06:10 pm
- Tuesday's Health Winners & Losers 10.16.07 | 04:10 pm
- Enzo Biochem Falls on Court Dismissal 09.07.07 | 02:09 pm
- Friday's Health Winners & Losers 09.07.07 | 02:09 pm
Press Releases for ENZ
- Enzo Biochem Reports Fiscal Second Quarter Results - Business Wire 03.12.13 | 04:03 pm
- Enzo Biochem Schedules Teleconference To Discuss Second Quarter Results On March 13, 2013 At 8:30 AM E.T. - Business Wire 03.08.13 | 01:03 pm
- Enzo Biochem Reports First Quarter Results - Business Wire 12.10.12 | 04:12 pm
- Enzo Biochem Schedules Teleconference To Discuss First Quarter Results On December 11, 2012 At 8:30 AM E.T. - Business Wire 12.06.12 | 11:12 am
- Enzo Biochem To Present At Canaccord Genuity 2012 Medical Technology & Diagnostics Forum - Business Wire 11.29.12 | 03:11 pm
- Enzo Biochem’s Clinical Labs Introduces Diagnostic Test That Assists In Early Detection Of Lung Cancer - Business Wire 11.13.12 | 07:11 am
- Enzo Biochem To Present At Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.12.12 | 11:11 am
- Enzo Biochem Reports Jury Declares Life Technologies Infringed Company Patents And Awards Enzo $48.6 Million - Business Wire 11.02.12 | 09:11 am
- Enzo Biochem Reports Fourth Quarter Results And Announces Realignment Program Expected To Reduce Annualized Costs $6 Million Commencing With Fiscal First Quarter - Business Wire 10.15.12 | 04:10 pm
- Enzo Biochem Schedules Teleconference To Discuss Fourth Quarter Results On October 16, 2012 At 8:30 AM E.T. - Business Wire 10.12.12 | 03:10 pm
Partner Headlines for ENZ
- Pre-Market Earnings Report for December 11, 2012 : DG, PTRY, ENZ, HSOL - NASDAQ 12.10.12 | 09:12 pm
- Investors Should Wait Out Quest & LabCorp - Seeking Alpha 02.16.12 | 09:02 am
- Enzo Biochem: Personalized Medicine Is More Than Targeted Therapeutics - Seeking Alpha 04.03.11 | 07:04 am
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- Top 5 Percentage Gainers On NYSE (DV, CKH, ENZ, LAD, CMG) - Benzinga 07.23.10 | 03:07 pm
- MB FINANCL INC (MBFI) - Profit Tracks - Zacks 04.13.10 | 01:04 am
- UPDATE 2-Enzo wins round in Applera patent fight - Reuters 03.26.10 | 04:03 pm
